✦ LIBER ✦

1420 THE EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF BI201335 AND BI207127 IN GENOTYPE 1 HCV PATIENTS WITH CIRRHOSIS - INTERIM ANALYSIS FROM SOUND-C2

✍ Scribed by Soriano, V.; Gane, E.; Angus, P.; Stickel, F.; Bronowicki, J.-P.; Roberts, S.; Manns, M.; Zeuzem, S.; Dai, L.; Boecher, W.; Stern, J.; Mensa, F.

Book ID: 121980444
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61431-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

101 SVR4 AND SVR12 WITH AN INTERFERON-FR

101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2

✍ S. Zeuzem; V. Soriano; T. Asselah; J.-P. Bronowicki; A. Lohse; B. Müllhaupt; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 158 KB

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONS

60 SILEN-C1: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE 1 HCV INFECTION

✍ M.S. Sulkowski; E. Ceasu; T. Asselah; F.A. Caruntu; J. Lalezari; P. Ferenci; A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

1186 ITPA GENE VARIANTS PREDICT HEMOLYTI

1186 ITPA GENE VARIANTS PREDICT HEMOLYTIC RIBAVIRIN INDUCED ANAEMIA IN PATIENTS TREATED WITH THE INTERFERON-FREE REGIMEN OF FALDAPREVIR, BI 207127 AND RIBAVIRIN IN SOUND-C2

✍ Asselah, T.; Zeuzem, S.; Soriano, V.; Bronowicki, J.-P.; Lohse, A.W.; Müllhaupt, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 305 KB

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY

1190 SILEN-C2: EARLY ANTIVIRAL ACTIVITY AND SAFETY OF BI 201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (PEGIFN/RBV) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO PEGIFN/RBV

✍ Sulkowski, M.; Bourliere, M.; Bronowicki, J.-P.; Streinu-Cercel, A.; Preotescu, 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 68 KB

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONS

66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/R

✍ M.S. Sulkowski; M. Bourliere; J.-P. Bronowicki; A. Streinu-Cercel; L. Preotescu; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

O111 SAFETY AND EFFICACY OF TREATMENT WI

O111 SAFETY AND EFFICACY OF TREATMENT WITH THE INTERFERON-FREE, RIBAVIRIN-FREE COMBINATION OF SOFOSBUVIR + GS-5816 FOR 12 WEEKS IN TREATMENT NAIVE PATIENTS WITH GENOTYPE 1–6 HCV INFECTION

✍ Everson, G.T.; Tran, T.T.; Towner, W.J.; Davis, M.N.; Wyles, D.; Nahass, R.; McN 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 87 KB